canmerry (Guangdong) Biomedical Technology Co., LTD. (hereinafter referred to as: CPI) is the holding enterprise of Canadian CPI Pharmaceutical Company in China. It is a high-tech biomedical enterprise specializing in the preparation and industrial application of nanobiologic active materials.

The first phase of the project is located in Nanfang Meigu Industrial Park, Huangpu District, Guangzhou. It has a high-standard GMP production workshop of 2000 square meters, which can produce high-active medical collagen, high-active nano collagen microspheres raw materials based on medical active collagen, strong bioactive skin care products, high-value medical devices and other products.

At the same time, relying on CPI's deep resources of scientific research experts, in September 2023 CPI and Guangzhou Development Zone Management Committee reached a cooperation agreement on the establishment of Crypto Rui (Guangdong) Biomedical Research Institute and academician's only workstation project in China. The company employs a number of well-known experts at home and abroad to lead CPI's high-level talent research and development team to conduct technical research and product development in the biomedical field.

With the world's leading technology, serve the Chinese market, and grow together with China. CPI has the research and development ability of canmerry Biomedical Research Institute, and the Chinese localization support of mature products of Canadian CPI pharmaceutical company, the market development prospect is broad, the potential is huge, and the future is promising.